Secretory products of the corpus luteum and preeclampsia | Zendy

Maria Monica Pereira | Zendy; Monica Mainigi | Zendy; Jerome F. Strauss | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Secretory products of the corpus luteum and preeclampsia

Author(s) -

Maria Monica Pereira,

Monica Mainigi,

Jerome F. Strauss

Publication year - 2021

Publication title -

human reproduction update

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.977

H-Index - 180

eISSN - 1362-4946

pISSN - 1355-4786

DOI - 10.1093/humupd/dmab003

Subject(s) - corpus luteum , preeclampsia , endometrium , embryo transfer , embryo , pregnancy , medicine , pathophysiology , gynecology , andrology , obstetrics , endocrinology , biology , ovary , microbiology and biotechnology , genetics

Despite significant advances in our understanding of the pathophysiology of preeclampsia (PE), there are still many unknowns and controversies in the field. Women undergoing frozen-thawed embryo transfer (FET) to a hormonally prepared endometrium have been found to have an unexpected increased risk of PE compared to women who receive embryos in a natural FET cycle. The differences in risk have been hypothesized to be related to the absence or presence of a functioning corpus luteum (CL).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research